Tag: TRI LIC

ProBio and GCP ClinPlus Partner to Accelerate Clinical Trials in China

ProBio and GCP ClinPlus today announced a strategic collaboration designed to accelerate Investigator-Initiated Trials (IITs) in China and provide integrated, end-to-end clinical and development...

Medidata and the University of Sydney’s NHMRC Clinical Trials Centre Broaden Efforts to Revolutionize Clinical Studies in Australia

Continuing collaboration will utilize the capabilities of the Medidata Data Experience, fostering efficiency, fast-tracking research breakthroughs, and raising the standard of clinical trials SINGAPORE,...

HanchorBio and Henlius Sign Major Licensing Deal for HCB101 to Expand Global Immuno-Oncology Reach

TAIPEI and SHANGHAI and SAN FRANCISCO, July 1, 2025 /PRNewswire/ -- HanchorBio Inc. (7827.TWO), a global clinical-stage biotechnology company developing innovative immunotherapies for oncology...

- A word from our sponsors -

HomeTagsTRI LIC

Hisense Partners with FIFA for First-Ever Sensory-Inclusive FIFA World Cup™

VEG ER for Pets Partners with VetRec to Advance AI-Powered Documentation Across Emergency Veterinary Care

Rent-to-Own Industry Generated $11.8 Billion in 2025 as 6.7 Million U.S. Households Seek Alternatives to Traditional Financing

Tag: TRI LIC

ProBio and GCP ClinPlus Partner to Accelerate Clinical Trials in China

Medidata and the University of Sydney’s NHMRC Clinical Trials Centre Broaden Efforts to Revolutionize Clinical Studies in Australia

HanchorBio and Henlius Sign Major Licensing Deal for HCB101 to Expand Global Immuno-Oncology Reach

Explore

Press Releases

News & Opinion

Living

Others

Follow us